News & Events
In the News
Aravax has appointed Louise Peacock as Chief Regulatory and Quality Officer
PharmaTimes
18 June 2025
Australia based Aravax is building out late stage manufacturing capabilities in Oxford, UK
BiotechTV
21 February 2025Biotech Aravax establishes UK subsidiary at Oxford Science Park
Insidermedia
15 November 2024Aravax Establishes Pharmaceutical Development Base on the Oxford Science Park With a Focus on Developing Manufacturing Capabilities in the UK
Drug Development & Delivery
14 November 2024Aravax’s Phase 2 Study Now Enrolling Children with Peanut Allergy
SnackSafely.com
21 May 2024Check Up: Aussie biotech Avarax on the verge of peanut allergy cure
STOCKHEAD
15 February 2024Aravax secures US$22M to close series B for peanut allergy therapy
BioWorld
29 January 2024View news [behind a paywall]
Aravax raises AU$66m for peanut allergy cure as Victoria leads the way
Business News Australia
24 January 2024Aravax raises US$20M series B round to take peanut allergy immunotherapy to phase II
BioWorld
27 December 2022View news [behind a paywall]
Celebrating Scientists and Researchers – Dr Sara Prickett
Australian Food Allergy Foundation
26 January 2017
